Pillsbury advised LiveOak Ventures, an Austin, Texas-based early-stage venture capital firm, in leading a $7.7 million funding round for Thrive Therapies, a Dallas, Texas-based provider of a technology-enabled pediatric healthcare platform.

The firm also advised Activate Venture Partners, an early-stage venture capital firm for high growth technology companies, in its participation in the round. Charter School Growth Fund also participated as an investor in the round.

According to recent coverage, Thrive Therapies plans to use the funding to expand into new markets, grow its clinical teams and further develop Thrive Clinical, its clinical intelligence platform.

Click here to read more.

The Pillsbury deal team was led by Corporate partner Andy Smetana and included counsel Patrick Dolan and associate Lee Alexander.